Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 1 year ago
In this short interview Dr James V Freeman (Yale University School of Medicine, New Haven, CT, US) discusses the key findings from the study investigating in-hospital outcomes for Next-Generation Watchman FLX compared with Watchman Generation 2.5. Discussion Points Importance of this Study Key Differences Between the Studied Devices Study Design and Patient Baseline Characteristics Key… View more
Author(s): Samir R Kapadia Added: 5 months ago
TCT 23 - We are joined by Dr Samir Kapadia (Cleveland Clinic, Cleveland, OH) to discuss the findings of the WATCH-TAVR Trial (NCT03173534). WATCH-TAVR aimed to evaluate the safety and effectiveness of left atrial appendage occlusion with the WATCHMAN device to prevent stroke and bleeding in patients with atrial fibrillation (AF) who are undergoing transcatheter aortic valve replacement (TAVR)… View more
Author(s): Dhanunjaya Lakkireddy Added: 1 year ago
TCT 2022 - Dr Dhanunjaya Lakkireddy (University of Kansas Hospital, Kansas City, US) joins us to discuss the safety and efficacy of the Amulet Left Atrial Appendage Occluder as suggested by the results of the AMULET-IDE Study. AMULET-IDE was a prospective, multi-center study with a cohort of 1878 patients with non-valvular atrial fibrillation. Participants were randomized to receive either the… View more
Author(s): Sunil Kapur , Moussa Mansour Added: 3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than three million Americans.1 The management of AF revolves around the alleviation of symptoms related to an accelerated and irregular ventricular response, and the prevention of cardioembolism, notably stroke. In patients with AF, there is a fivefold increased incidence of embolic stroke.2 The prevention of systemic… View more
Research Area(s) / Expertise:
Dr Pugazhendhi Vijayaraman obtained his medical degree from Madurai Medical College and completed his residency at Jacobi Medical Center. He completed his fellowships in cardiovascular diseases and clinical cardiac electrophysiology at the Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center. Dr Vijayaraman specialises in cardiac electrophysiology, cardiac… View more
Added: 3 years ago
Dr Shephal Doshi (Pacific Heart Institute, Santa Monica, CA, US) discusses the results from the PINNACLE FLX Study. The PINNACLE FLX Study is a prospective, non-randomized, multi-center investigation to establish the safety and effectiveness of the WATCHMAN FLX™ Left Atrial Appendage Closure Device for subjects with non-valvular atrial fibrillation who are eligible for long-term anti-coagulation… View more
Author(s): Wern Yew Ding , Dhiraj Gupta Added: 3 years ago
AF is associated with an increased risk of thromboembolic events.1,2 Risk scores are used to identify patients at high risk of such complications who may benefit from anticoagulation therapy.3 However, despite a broad range of anticoagulant options and improved uptake in anticoagulation over the past decade, there are limitations to this approach. First, there is a significant proportion of high… View more